Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Garber

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Experimental Psychology. Applied|March 31, 2010
Following your heart or your head: focusing on emotions versus information differentially influences the decisions of younger and older adultsJoseph A Mikels, Corinna E Löckenhoff, Sam J Maglio, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 18, 2015
COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETESMatthew P Gilbert, Michel Marre, Jens Juul Holst, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 2011
Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide Effect and Action in Diabetes (LEAD) trialsJohn B Buse, Alan Garber, Julio Rosenstock, et al.
Lancet (London, England)|September 30, 2008
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trialAlan Garber, Robert Henry, Robert Ratner, et al.
Circulation|July 17, 2013
Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trialRichard G Bach, Maria Mori Brooks, Manuel Lombardero, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Experimental Psychology. Applied|March 31, 2010
Following your heart or your head: focusing on emotions versus information differentially influences the decisions of younger and older adultsJoseph A Mikels, Corinna E Löckenhoff, Sam J Maglio, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 18, 2015
COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETESMatthew P Gilbert, Michel Marre, Jens Juul Holst, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 2011
Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide Effect and Action in Diabetes (LEAD) trialsJohn B Buse, Alan Garber, Julio Rosenstock, et al.
Lancet (London, England)|September 30, 2008
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trialAlan Garber, Robert Henry, Robert Ratner, et al.
Circulation|July 17, 2013
Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trialRichard G Bach, Maria Mori Brooks, Manuel Lombardero, et al.
Pageof 2